SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-089351
Filing Date
2022-08-11
Accepted
2022-08-11 16:10:17
Documents
14
Period of Report
2022-08-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2223185d1_8k.htm   iXBRL 8-K 26107
2 EXHIBIT 99.1 tm2223185d1_ex99-1.htm EX-99.1 68680
6 GRAPHIC tm2223185d1_ex99-1img001.jpg GRAPHIC 2139
  Complete submission text file 0001104659-22-089351.txt   277500

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA armp-20220811.xsd EX-101.SCH 3045
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE armp-20220811_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE armp-20220811_pre.xml EX-101.PRE 22603
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2223185d1_8k_htm.xml XML 3474
Mailing Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292
Business Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37544 | Film No.: 221155812
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences